Anti-herpetic Medications and Reduced Risk of Dementia in Patients with Herpes Simplex Virus Infections-a Nationwide, Population-Based Cohort Study in Taiwan.
Neurotherapeutics. 2018 Apr; 15(2):417-429.N

Abstract

This retrospective cohort study is to investigate the association between herpes simplex virus (HSV) infections and dementia, and the effects of anti-herpetic medications on the risk involved, using Taiwan's National Health Insurance Research Database (NHIRD). We enrolled a total of 33,448 subjects, and identified 8362 with newly diagnosed HSV infections and 25,086 randomly selected sex- and age-matched controls without HSV infections in a ratio of 1:3, selected from January 1, to December 31, 2000. A multivariable Cox proportional hazards regression model was used to evaluate the risk of developing dementia in the HSV cohort. This analysis revealed an adjusted hazard ratio of 2.564 (95% CI: 2.351-2.795, P < 0.001) for the development of dementia in the HSV-infected cohort relative to the non-HSV cohort. Thus, patients with HSV infections may have a 2.56-fold increased risk of developing dementia. A risk reduction of dementia development in patients affected by HSV infections was found upon treatment with anti-herpetic medications (adjusted HR = 0.092 [95% CI 0.079-0.108], P < 0.001). The usage of anti-herpetic medications in the treatment of HSV infections was associated with a decreased risk of dementia. These findings could be a signal to clinicians caring for patients with HSV infections. Further research is, therefore, necessary to explore the underlying mechanism(s) of these associations.

Links

PMC Free PDF

Authors+Show Affiliations

Tzeng NS

Department of Psychiatry, Tri-Service General Hospital, School of Medicine, National Defense Medical Center, Taipei, Taiwan, Republic of China. Student Counseling Center, National Defense Medical Center, Taipei, Taiwan, Republic of China.

Chung CH

Taiwanese Injury Prevention and Safety Promotion Association, Taipei, Taiwan, Republic of China. School of Public Health, National Defense Medical Center, Taipei, Taiwan, Republic of China. Department of Medical Research, Tri-Service General Hospital, National Defense Medical Center, 7115R, No.325, Section 2, Cheng-Kung Road, Neihu District, Taipei City, 11490, Taiwan, Republic of China.

Lin FH

School of Public Health, National Defense Medical Center, Taipei, Taiwan, Republic of China.

Chiang CP

Department of Dermatology, Tri-Service General Hospital, School of Medicine, National Defense Medical Center, Taipei, Taiwan, Republic of China.

Yeh CB

Department of Psychiatry, Tri-Service General Hospital, School of Medicine, National Defense Medical Center, Taipei, Taiwan, Republic of China. Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan, Republic of China.

Huang SY

Lu RB

Department of Psychiatry, Tri-Service General Hospital, School of Medicine, National Defense Medical Center, Taipei, Taiwan, Republic of China. Division of Clinical Psychology, Institute of Allied Health Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Republic of China. Department of Psychiatry, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Republic of China. Institute of Behavioral Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Republic of China. Department of Psychiatry, National Cheng Kung University Hospital, Tainan, Taiwan, Republic of China. Center for Neuropsychiatric Research, National Health Research Institute, Zhunan, Miaoli County, Taiwan, Republic of China.

Chang HA

Kao YC

Department of Psychiatry, Tri-Service General Hospital, School of Medicine, National Defense Medical Center, Taipei, Taiwan, Republic of China. Department of Psychiatry, Tri-Service General Hospital, Song-Shan Branch, National Defense Medical Center, Taipei, Taiwan, Republic of China.

Yeh HW

Department of Psychiatry, Tri-Service General Hospital, School of Medicine, National Defense Medical Center, Taipei, Taiwan, Republic of China.

Chiang WS

Department of Psychiatry, Tri-Service General Hospital, School of Medicine, National Defense Medical Center, Taipei, Taiwan, Republic of China. Department and Institute of Mathematics, Tamkang University, New Taipei City, Taiwan, Republic of China.

Chou YC

School of Public Health, National Defense Medical Center, Taipei, Taiwan, Republic of China.

Tsao CH

Department of Medical Research, Tri-Service General Hospital, National Defense Medical Center, 7115R, No.325, Section 2, Cheng-Kung Road, Neihu District, Taipei City, 11490, Taiwan, Republic of China.

Wu YF

Chien WC

School of Public Health, National Defense Medical Center, Taipei, Taiwan, Republic of China. chienwu@ndmctsgh.edu.tw. Department of Medical Research, Tri-Service General Hospital, National Defense Medical Center, 7115R, No.325, Section 2, Cheng-Kung Road, Neihu District, Taipei City, 11490, Taiwan, Republic of China. chienwu@ndmctsgh.edu.tw.

MeSH

AgedAntiviral AgentsDementiaFemaleHerpes SimplexHumansMaleMiddle AgedProportional Hazards ModelsRetrospective StudiesRisk FactorsTaiwan

Pub Type(s)

Journal Article

Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

29488144

Citation

Tzeng, Nian-Sheng, et al. "Anti-herpetic Medications and Reduced Risk of Dementia in Patients With Herpes Simplex Virus Infections-a Nationwide, Population-Based Cohort Study in Taiwan." Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics, vol. 15, no. 2, 2018, pp. 417-429.

Tzeng NS, Chung CH, Lin FH, et al. Anti-herpetic Medications and Reduced Risk of Dementia in Patients with Herpes Simplex Virus Infections-a Nationwide, Population-Based Cohort Study in Taiwan. Neurotherapeutics. 2018;15(2):417-429.

Tzeng, N. S., Chung, C. H., Lin, F. H., Chiang, C. P., Yeh, C. B., Huang, S. Y., Lu, R. B., Chang, H. A., Kao, Y. C., Yeh, H. W., Chiang, W. S., Chou, Y. C., Tsao, C. H., Wu, Y. F., & Chien, W. C. (2018). Anti-herpetic Medications and Reduced Risk of Dementia in Patients with Herpes Simplex Virus Infections-a Nationwide, Population-Based Cohort Study in Taiwan. Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics, 15(2), 417-429. https://doi.org/10.1007/s13311-018-0611-x

Tzeng NS, et al. Anti-herpetic Medications and Reduced Risk of Dementia in Patients With Herpes Simplex Virus Infections-a Nationwide, Population-Based Cohort Study in Taiwan. Neurotherapeutics. 2018;15(2):417-429. PubMed PMID: 29488144.

* Article titles in AMA citation format should be in sentence-case

TY - JOUR T1 - Anti-herpetic Medications and Reduced Risk of Dementia in Patients with Herpes Simplex Virus Infections-a Nationwide, Population-Based Cohort Study in Taiwan. AU - Tzeng,Nian-Sheng, AU - Chung,Chi-Hsiang, AU - Lin,Fu-Huang, AU - Chiang,Chien-Ping, AU - Yeh,Chin-Bin, AU - Huang,San-Yuan, AU - Lu,Ru-Band, AU - Chang,Hsin-An, AU - Kao,Yu-Chen, AU - Yeh,Hui-Wen, AU - Chiang,Wei-Shan, AU - Chou,Yu-Ching, AU - Tsao,Chang-Huei, AU - Wu,Yung-Fu, AU - Chien,Wu-Chien, PY - 2018/3/1/pubmed PY - 2019/3/14/medline PY - 2018/3/1/entrez KW - Anti-herpetic medications KW - Cohort study KW - Dementia KW - Herpes simplex virus KW - National Health Insurance Research Database SP - 417 EP - 429 JF - Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics JO - Neurotherapeutics VL - 15 IS - 2 N2 - This retrospective cohort study is to investigate the association between herpes simplex virus (HSV) infections and dementia, and the effects of anti-herpetic medications on the risk involved, using Taiwan's National Health Insurance Research Database (NHIRD). We enrolled a total of 33,448 subjects, and identified 8362 with newly diagnosed HSV infections and 25,086 randomly selected sex- and age-matched controls without HSV infections in a ratio of 1:3, selected from January 1, to December 31, 2000. A multivariable Cox proportional hazards regression model was used to evaluate the risk of developing dementia in the HSV cohort. This analysis revealed an adjusted hazard ratio of 2.564 (95% CI: 2.351-2.795, P < 0.001) for the development of dementia in the HSV-infected cohort relative to the non-HSV cohort. Thus, patients with HSV infections may have a 2.56-fold increased risk of developing dementia. A risk reduction of dementia development in patients affected by HSV infections was found upon treatment with anti-herpetic medications (adjusted HR = 0.092 [95% CI 0.079-0.108], P < 0.001). The usage of anti-herpetic medications in the treatment of HSV infections was associated with a decreased risk of dementia. These findings could be a signal to clinicians caring for patients with HSV infections. Further research is, therefore, necessary to explore the underlying mechanism(s) of these associations. SN - 1878-7479 UR - https://www.unboundmedicine.com/medline/citation/29488144/full_citation DB - PRIME DP - Unbound Medicine ER -

Tags

Anti-herpetic Medications and Reduced Risk of Dementia in Patients with Herpes Simplex Virus Infections-a Nationwide, Population-Based Cohort Study in Taiwan.Neurotherapeutics. 2018 Apr; 15(2):417-429.N